Navenibart 150mg/ml clinical trials

Astria STAR-0215-302 trial for Navenibart in Hereditary Angioedema

This study looks at a new medicine called navenibart for hereditary angioedema (HAE). It aims to see how safe it is and how well people tolerate it over a long time. Navenibart might help prevent HAE attacks, which can be severe and painful.